Home Healthcare Biotechnology Blood Screening Market

Blood Screening Market Size, Share & Trends Analysis Report By Technology (Nucleic Acid Amplification Test (NAT), ELISA, Chemiluminescence Immunoassay (CLIA & EIA ), Next Generation Sequencing (NGS), Western Blotting (WB)), By Product (Reagent, Instrument) and By Region (North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2026-2034

Last Updated: June 03, 2026 | Author: Jay Mehta | Format:
Overview TOC Segmentation Methodology
Download Free Sample

Market Segmentation

  1. Blood Screening Market, By Technology 2022-2034 (USD MILLION/ Units)
    1. Nucleic Acid Amplification Test (NAT)
    2. ELISA
    3. Chemiluminescence Immunoassay (CLIA & EIA )
    4. Next Generation Sequencing (NGS)
    5. Western Blotting (WB)
  2. Blood Screening Market, By Product 2022-2034 (USD MILLION/ Units)
    1. Reagent
    2. Instrument
  3. Regional Blood Screening Market
    1. North America
      1. North America Blood Screening Market By Technology 2022-2034 (USD MILLION/ Units)
        1. Nucleic Acid Amplification Test (NAT)
        2. ELISA
        3. Chemiluminescence Immunoassay (CLIA & EIA )
        4. Next Generation Sequencing (NGS)
        5. Western Blotting (WB)
      2. North America Blood Screening Market By Product 2022-2034 (USD MILLION/ Units)
        1. Reagent
        2. Instrument
      3. U.S.
        1. Nucleic Acid Amplification Test (NAT)
        2. ELISA
        3. Chemiluminescence Immunoassay (CLIA & EIA )
        4. Next Generation Sequencing (NGS)
        5. Western Blotting (WB)
        6. Reagent
        7. Instrument
      4. Canada
        1. Nucleic Acid Amplification Test (NAT)
        2. ELISA
        3. Chemiluminescence Immunoassay (CLIA & EIA )
        4. Next Generation Sequencing (NGS)
        5. Western Blotting (WB)
        6. Reagent
        7. Instrument
    2. Europe
      1. Europe Blood Screening Market By Technology 2022-2034 (USD MILLION/ Units)
        1. Nucleic Acid Amplification Test (NAT)
        2. ELISA
        3. Chemiluminescence Immunoassay (CLIA & EIA )
        4. Next Generation Sequencing (NGS)
        5. Western Blotting (WB)
      2. Europe Blood Screening Market By Product 2022-2034 (USD MILLION/ Units)
        1. Reagent
        2. Instrument
      3. U.K.
        1. Nucleic Acid Amplification Test (NAT)
        2. ELISA
        3. Chemiluminescence Immunoassay (CLIA & EIA )
        4. Next Generation Sequencing (NGS)
        5. Western Blotting (WB)
        6. Reagent
        7. Instrument
      4. Germany
        1. Nucleic Acid Amplification Test (NAT)
        2. ELISA
        3. Chemiluminescence Immunoassay (CLIA & EIA )
        4. Next Generation Sequencing (NGS)
        5. Western Blotting (WB)
        6. Reagent
        7. Instrument
      5. France
        1. Nucleic Acid Amplification Test (NAT)
        2. ELISA
        3. Chemiluminescence Immunoassay (CLIA & EIA )
        4. Next Generation Sequencing (NGS)
        5. Western Blotting (WB)
        6. Reagent
        7. Instrument
      6. Spain
        1. Nucleic Acid Amplification Test (NAT)
        2. ELISA
        3. Chemiluminescence Immunoassay (CLIA & EIA )
        4. Next Generation Sequencing (NGS)
        5. Western Blotting (WB)
        6. Reagent
        7. Instrument
      7. Italy
        1. Nucleic Acid Amplification Test (NAT)
        2. ELISA
        3. Chemiluminescence Immunoassay (CLIA & EIA )
        4. Next Generation Sequencing (NGS)
        5. Western Blotting (WB)
        6. Reagent
        7. Instrument
      8. Russia
        1. Nucleic Acid Amplification Test (NAT)
        2. ELISA
        3. Chemiluminescence Immunoassay (CLIA & EIA )
        4. Next Generation Sequencing (NGS)
        5. Western Blotting (WB)
        6. Reagent
        7. Instrument
      9. Nordic
        1. Nucleic Acid Amplification Test (NAT)
        2. ELISA
        3. Chemiluminescence Immunoassay (CLIA & EIA )
        4. Next Generation Sequencing (NGS)
        5. Western Blotting (WB)
        6. Reagent
        7. Instrument
      10. Benelux
        1. Nucleic Acid Amplification Test (NAT)
        2. ELISA
        3. Chemiluminescence Immunoassay (CLIA & EIA )
        4. Next Generation Sequencing (NGS)
        5. Western Blotting (WB)
        6. Reagent
        7. Instrument
      11. Rest of Europe
        1. Nucleic Acid Amplification Test (NAT)
        2. ELISA
        3. Chemiluminescence Immunoassay (CLIA & EIA )
        4. Next Generation Sequencing (NGS)
        5. Western Blotting (WB)
        6. Reagent
        7. Instrument
    3. APAC
      1. APAC Blood Screening Market By Technology 2022-2034 (USD MILLION/ Units)
        1. Nucleic Acid Amplification Test (NAT)
        2. ELISA
        3. Chemiluminescence Immunoassay (CLIA & EIA )
        4. Next Generation Sequencing (NGS)
        5. Western Blotting (WB)
      2. APAC Blood Screening Market By Product 2022-2034 (USD MILLION/ Units)
        1. Reagent
        2. Instrument
      3. China
        1. Nucleic Acid Amplification Test (NAT)
        2. ELISA
        3. Chemiluminescence Immunoassay (CLIA & EIA )
        4. Next Generation Sequencing (NGS)
        5. Western Blotting (WB)
        6. Reagent
        7. Instrument
      4. Korea
        1. Nucleic Acid Amplification Test (NAT)
        2. ELISA
        3. Chemiluminescence Immunoassay (CLIA & EIA )
        4. Next Generation Sequencing (NGS)
        5. Western Blotting (WB)
        6. Reagent
        7. Instrument
      5. Japan
        1. Nucleic Acid Amplification Test (NAT)
        2. ELISA
        3. Chemiluminescence Immunoassay (CLIA & EIA )
        4. Next Generation Sequencing (NGS)
        5. Western Blotting (WB)
        6. Reagent
        7. Instrument
      6. India
        1. Nucleic Acid Amplification Test (NAT)
        2. ELISA
        3. Chemiluminescence Immunoassay (CLIA & EIA )
        4. Next Generation Sequencing (NGS)
        5. Western Blotting (WB)
        6. Reagent
        7. Instrument
      7. Australia
        1. Nucleic Acid Amplification Test (NAT)
        2. ELISA
        3. Chemiluminescence Immunoassay (CLIA & EIA )
        4. Next Generation Sequencing (NGS)
        5. Western Blotting (WB)
        6. Reagent
        7. Instrument
      8. Singapore
        1. Nucleic Acid Amplification Test (NAT)
        2. ELISA
        3. Chemiluminescence Immunoassay (CLIA & EIA )
        4. Next Generation Sequencing (NGS)
        5. Western Blotting (WB)
        6. Reagent
        7. Instrument
      9. Taiwan
        1. Nucleic Acid Amplification Test (NAT)
        2. ELISA
        3. Chemiluminescence Immunoassay (CLIA & EIA )
        4. Next Generation Sequencing (NGS)
        5. Western Blotting (WB)
        6. Reagent
        7. Instrument
      10. South East Asia
        1. Nucleic Acid Amplification Test (NAT)
        2. ELISA
        3. Chemiluminescence Immunoassay (CLIA & EIA )
        4. Next Generation Sequencing (NGS)
        5. Western Blotting (WB)
        6. Reagent
        7. Instrument
      11. Rest of Asia-Pacific
        1. Nucleic Acid Amplification Test (NAT)
        2. ELISA
        3. Chemiluminescence Immunoassay (CLIA & EIA )
        4. Next Generation Sequencing (NGS)
        5. Western Blotting (WB)
        6. Reagent
        7. Instrument
    4. Middle East and Africa
      1. Middle East and Africa Blood Screening Market By Technology 2022-2034 (USD MILLION/ Units)
        1. Nucleic Acid Amplification Test (NAT)
        2. ELISA
        3. Chemiluminescence Immunoassay (CLIA & EIA )
        4. Next Generation Sequencing (NGS)
        5. Western Blotting (WB)
      2. Middle East and Africa Blood Screening Market By Product 2022-2034 (USD MILLION/ Units)
        1. Reagent
        2. Instrument
      3. UAE
        1. Nucleic Acid Amplification Test (NAT)
        2. ELISA
        3. Chemiluminescence Immunoassay (CLIA & EIA )
        4. Next Generation Sequencing (NGS)
        5. Western Blotting (WB)
        6. Reagent
        7. Instrument
      4. Turkey
        1. Nucleic Acid Amplification Test (NAT)
        2. ELISA
        3. Chemiluminescence Immunoassay (CLIA & EIA )
        4. Next Generation Sequencing (NGS)
        5. Western Blotting (WB)
        6. Reagent
        7. Instrument
      5. Saudi Arabia
        1. Nucleic Acid Amplification Test (NAT)
        2. ELISA
        3. Chemiluminescence Immunoassay (CLIA & EIA )
        4. Next Generation Sequencing (NGS)
        5. Western Blotting (WB)
        6. Reagent
        7. Instrument
      6. South Africa
        1. Nucleic Acid Amplification Test (NAT)
        2. ELISA
        3. Chemiluminescence Immunoassay (CLIA & EIA )
        4. Next Generation Sequencing (NGS)
        5. Western Blotting (WB)
        6. Reagent
        7. Instrument
      7. Egypt
        1. Nucleic Acid Amplification Test (NAT)
        2. ELISA
        3. Chemiluminescence Immunoassay (CLIA & EIA )
        4. Next Generation Sequencing (NGS)
        5. Western Blotting (WB)
        6. Reagent
        7. Instrument
      8. Nigeria
        1. Nucleic Acid Amplification Test (NAT)
        2. ELISA
        3. Chemiluminescence Immunoassay (CLIA & EIA )
        4. Next Generation Sequencing (NGS)
        5. Western Blotting (WB)
        6. Reagent
        7. Instrument
      9. Rest of MEA
        1. Nucleic Acid Amplification Test (NAT)
        2. ELISA
        3. Chemiluminescence Immunoassay (CLIA & EIA )
        4. Next Generation Sequencing (NGS)
        5. Western Blotting (WB)
        6. Reagent
        7. Instrument
    5. LATAM
      1. LATAM Blood Screening Market By Technology 2022-2034 (USD MILLION/ Units)
        1. Nucleic Acid Amplification Test (NAT)
        2. ELISA
        3. Chemiluminescence Immunoassay (CLIA & EIA )
        4. Next Generation Sequencing (NGS)
        5. Western Blotting (WB)
      2. LATAM Blood Screening Market By Product 2022-2034 (USD MILLION/ Units)
        1. Reagent
        2. Instrument
      3. Brazil
        1. Nucleic Acid Amplification Test (NAT)
        2. ELISA
        3. Chemiluminescence Immunoassay (CLIA & EIA )
        4. Next Generation Sequencing (NGS)
        5. Western Blotting (WB)
        6. Reagent
        7. Instrument
      4. Mexico
        1. Nucleic Acid Amplification Test (NAT)
        2. ELISA
        3. Chemiluminescence Immunoassay (CLIA & EIA )
        4. Next Generation Sequencing (NGS)
        5. Western Blotting (WB)
        6. Reagent
        7. Instrument
      5. Argentina
        1. Nucleic Acid Amplification Test (NAT)
        2. ELISA
        3. Chemiluminescence Immunoassay (CLIA & EIA )
        4. Next Generation Sequencing (NGS)
        5. Western Blotting (WB)
        6. Reagent
        7. Instrument
      6. Chile
        1. Nucleic Acid Amplification Test (NAT)
        2. ELISA
        3. Chemiluminescence Immunoassay (CLIA & EIA )
        4. Next Generation Sequencing (NGS)
        5. Western Blotting (WB)
        6. Reagent
        7. Instrument
      7. Colombia
        1. Nucleic Acid Amplification Test (NAT)
        2. ELISA
        3. Chemiluminescence Immunoassay (CLIA & EIA )
        4. Next Generation Sequencing (NGS)
        5. Western Blotting (WB)
        6. Reagent
        7. Instrument
      8. Rest of LATAM
        1. Nucleic Acid Amplification Test (NAT)
        2. ELISA
        3. Chemiluminescence Immunoassay (CLIA & EIA )
        4. Next Generation Sequencing (NGS)
        5. Western Blotting (WB)
        6. Reagent
        7. Instrument
Report Details
−
200+ Trusted Partners
LG Electronics AMCAD Engineering KOBE STEEL LTD. Hindustan National Glass & Industries Limited Voith Group International Paper Hansol Paper Whirlpool Corporation Sony Samsung Electronics Qualcomm Google Fiserv Veto-Pharma Nippon Becton Dickinson Merck Argon Medical Devices Abbott Ajinomoto Denon Doosan Meiji Seika Kaisha Ltd LG Chemicals LCY chemical group Bayer Airrane BASF Toyota Industries Nissan Motors Neenah Mitsubishi Hyundai Motor Company Honda CRP Industries Inc pewag LGE Panasonic Lubrizol Corporation Leonardo Johnson & Johnson HB Fuller MITSUBISHI CHEMICAL Hyundai Mobis Amazon
Download Free Sample
Reach out to us
+1 646 905 0080 (U.S.)
+44 203 695 0070 (U.K.)
sales@straitsresearch.com

We are featured on:

Straits Research
Address:
105, Panchshil The Golden Bell,
Koregaon Park Annexe, Mundhwa,
Pune, Maharashtra 411036
Contact Us:
+1 646 905 0080 (U.S.)
+91 8087085354 (India)
+44 203 695 0070 (U.K.)

sales@straitsresearch.com

Quick Links
Help
Verified. Protected. Secure.
Duns
DMCA.com Protection Status
lets-encrypt
Secure Payments:
Secure Payments
Follow Us:
www.straitsresearch.com © Copyright . All rights Reserved.